The Impact of Consenter Characteristics and Experience on Patient Interest in Clinical Research
Authors:
Open Access
- 28 April 2009
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 14 (5) , 468-475
Abstract
Background.To explain the historically low rates of participation in cancer clinical trials, several factors have been studied. These include subject characteristics and attitudes, clinical trial availability and eligibility criteria, and physician attitudes and communication skills. However, the impact of nonphysician research personnel, who often consent patients for studies, is unclear. We therefore evaluated the association between consenter characteristics and subject interest in clinical research. Methods.We performed a retrospective review of subjects enrolled in a university-based cancer center tissue repository. During enrollment, subjects were asked if they were willing to be contacted in the future to (a) provide medical follow-up information and (b) participate in other clinical research. We analyzed the association between responses to these questions and consenter characteristics using univariate analysis and multivariate logistic regression. Results.In total, 181 consenters enrolled 922 subjects. The majority of subjects agreed to be contacted for follow-up (84.9%) and future research (83.1%). Subject willingness to be contacted for future research was associated with greater consenter experience in univariate and multivariate analyses. In multivariate analysis, subject willingness to be contacted for future research was associated with discordance between subject and consenter gender, but not with subject gender, race, or income, or consenter gender or race. Conclusions.Consenter experience and subject–consenter gender discordance were associated with greater subject interest in participating in future research. The role of consenters in clinical research merits future study and should be considered in efforts to increase cancer clinical trial accrual.Keywords
This publication has 27 references indexed in Scilit:
- Provider roles in the recruitment of underrepresented populations to cancer clinical trialsCancer, 2007
- Lay patient navigator program implementation for equal access to cancer care and clinical trialsCancer, 2006
- Predictors of enrollment in lung cancer clinical trialsCancer, 2005
- Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug AdministrationJournal of Clinical Oncology, 2004
- Participation in Cancer Clinical TrialsJAMA, 2004
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- Barriers to the participation of African‐American patients with cancer in clinical trialsCancer, 2003
- How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsJournal of Clinical Oncology, 2002
- Factors that influence African-Americans' willingness to participate in medical research studiesCancer, 2001
- Viability of Cancer Clinical Research: Patient Accrual, Coverage, and Reimbursement: American Medical Association Council on scientific AffairsJNCI: Journal of the National Cancer Institute, 1991